Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Case

Showing results (241-250 of 252) with videos related to

Pageof 26
Sort By:
Bioorganic & Medicinal Chemistry Letters|June 26, 2003
Structure-based drug design of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complexMichael S South, Brenda L Case, Rhonda S Wood, et al.
Human Molecular Genetics|August 28, 2007
A functional polymorphism of the Galphaq (GNAQ) gene is associated with accelerated mortality in African-American heart failureStephen B Liggett, Reagan J Kelly, Rohan R Parekh, et al.
Journal of Medicinal Chemistry|August 3, 2010
Discovery of novel cyanodihydropyridines as potent mineralocorticoid receptor antagonistsGraciela B Arhancet, Scott S Woodard, Kaliappan Iyanar, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2007
The synthesis and biological evaluation of novel series of nitrile-containing fluoroquinolones as antibacterial agentsSean T Murphy, Heather L Case, Edmund Ellsworth, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 6, 2023
Targeting Astrocyte Signaling Alleviates Cerebrovascular and Synaptic Function Deficits in a Diet-Based Mouse Model of Small Cerebral Vessel DiseasePradoldej Sompol, Jenna L Gollihue, Blaine E Weiss, et al.
Journal of Medicinal Chemistry|September 5, 2003
Design, parallel synthesis, and crystal structures of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complexJohn J Parlow, Brenda L Case, Thomas A Dice, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 16, 2010
Biochemical, cellular, and anti-inflammatory properties of a potent, selective, orally bioavailable benzamide inhibitor of Rho kinase activityLakshman E Rajagopalan, Michael S Davies, Larry E Kahn, et al.
The Journal of Antibiotics|October 10, 1998
Discovery of MC-02,331, a new cephalosporin exhibiting potent activity against methicillin-resistant Staphylococcus aureusS J Hecker, I S Cho, T W Glinka, et al.
The Lancet. Infectious Diseases|May 14, 2022
Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trialEmily E Coates, Srilatha Edupuganti, Grace L Chen, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of an Oral Potent Selective Inhibitor of Hematopoietic Prostaglandin D Synthase (HPGDS)Chris P Carron, John I Trujillo, Kirk L Olson, et al.
Pageof 26

Showing results (241-250 of 252) with videos related to

Sort By:
Pageof 26
Bioorganic & Medicinal Chemistry Letters|June 26, 2003
Structure-based drug design of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complexMichael S South, Brenda L Case, Rhonda S Wood, et al.
Human Molecular Genetics|August 28, 2007
A functional polymorphism of the Galphaq (GNAQ) gene is associated with accelerated mortality in African-American heart failureStephen B Liggett, Reagan J Kelly, Rohan R Parekh, et al.
Journal of Medicinal Chemistry|August 3, 2010
Discovery of novel cyanodihydropyridines as potent mineralocorticoid receptor antagonistsGraciela B Arhancet, Scott S Woodard, Kaliappan Iyanar, et al.
Bioorganic & Medicinal Chemistry Letters|February 17, 2007
The synthesis and biological evaluation of novel series of nitrile-containing fluoroquinolones as antibacterial agentsSean T Murphy, Heather L Case, Edmund Ellsworth, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 6, 2023
Targeting Astrocyte Signaling Alleviates Cerebrovascular and Synaptic Function Deficits in a Diet-Based Mouse Model of Small Cerebral Vessel DiseasePradoldej Sompol, Jenna L Gollihue, Blaine E Weiss, et al.
Journal of Medicinal Chemistry|September 5, 2003
Design, parallel synthesis, and crystal structures of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complexJohn J Parlow, Brenda L Case, Thomas A Dice, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 16, 2010
Biochemical, cellular, and anti-inflammatory properties of a potent, selective, orally bioavailable benzamide inhibitor of Rho kinase activityLakshman E Rajagopalan, Michael S Davies, Larry E Kahn, et al.
The Journal of Antibiotics|October 10, 1998
Discovery of MC-02,331, a new cephalosporin exhibiting potent activity against methicillin-resistant Staphylococcus aureusS J Hecker, I S Cho, T W Glinka, et al.
The Lancet. Infectious Diseases|May 14, 2022
Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trialEmily E Coates, Srilatha Edupuganti, Grace L Chen, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Discovery of an Oral Potent Selective Inhibitor of Hematopoietic Prostaglandin D Synthase (HPGDS)Chris P Carron, John I Trujillo, Kirk L Olson, et al.
Pageof 26